Guided Therapeutics (GTHP) Non-Current Assets (2010 - 2025)

Guided Therapeutics recorded quarterly Non-Current Assets of $719000.0 in Q4 2025, up 591.35% quarter-over-quarter from $104000.0 in Q3 2025, and up 297.24% year-over-year from $181000.0 in Q4 2024.

Guided Therapeutics' Non-Current Assets history runs 16 years deep, the most recent figure standing at $719000.0 for Q4 2025.

  • In Q4 2025, Non-Current Assets rose 297.24% year-over-year to $719000.0; the TTM figure through Dec 2025 stood at $719000.0 (up 297.24% YoY), while the FY2025 annual figure was $719000.0, up 297.24% from the prior year.
  • Non-Current Assets came in at $719000.0 for Q4 2025 at Guided Therapeutics, up from $104000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $719000.0 in Q4 2025 to a low of $104000.0 in Q3 2025.
  • A 5-year average of $322450.0 and a median of $330500.0 in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets jumped 570.97% in 2021 and plunged 49.51% in 2025, its largest moves.
  • Guided Therapeutics' Non-Current Assets stood at $403000.0 in 2021, then fell by 10.17% to $362000.0 in 2022, then decreased by 23.76% to $276000.0 in 2023, then plunged by 34.42% to $181000.0 in 2024, then jumped by 297.24% to $719000.0 in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $719000.0, $104000.0, and $129000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 84.92 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 32.95 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 67.41 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 35.67 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 7.09 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.47 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.30 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 26.70 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.34 Bn
10 Guided Therapeutics - - 458,000.00 719,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 719,000.00
Sep 30, 2025 104,000.00
Jun 30, 2025 129,000.00
Mar 31, 2025 156,000.00
Dec 31, 2024 181,000.00
Sep 30, 2024 206,000.00
Jun 30, 2024 230,000.00
Mar 31, 2024 254,000.00
Dec 31, 2023 276,000.00
Sep 30, 2023 299,000.00
Jun 30, 2023 319,000.00
Mar 31, 2023 342,000.00
Dec 31, 2022 362,000.00
Sep 30, 2022 380,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 400,000.00
Dec 31, 2021 403,000.00
Sep 30, 2021 416,000.00
Jun 30, 2021 427,000.00
Mar 31, 2021 446,000.00
Dec 31, 2020 454,000.00
Sep 30, 2020 62,000.00
Jun 30, 2020 87,000.00
Mar 31, 2020 126,000.00
Dec 31, 2019 150,000.00
Sep 30, 2019 171,000.00
Jun 30, 2019 194,000.00
Mar 31, 2019 237,000.00
Dec 31, 2018 19,000.00
Sep 30, 2018 44,000.00
Jun 30, 2018 50,000.00
Mar 31, 2018 61,000.00
Dec 31, 2017 60,000.00
Sep 30, 2017 75,000.00
Jun 30, 2017 319,000.00
Mar 31, 2017 319,000.00
Dec 31, 2016 446,000.00
Sep 30, 2016 196,000.00
Jun 30, 2016 262,000.00
Mar 31, 2016 318,000.00
Dec 31, 2015 391,000.00
Sep 30, 2015 108,000.00
Jun 30, 2015 768,000.00
Mar 31, 2015 93,000.00
Dec 31, 2014 1.25 Mn
Sep 30, 2014 132,000.00
Jun 30, 2014 343,000.00
Mar 31, 2014 315,000.00
Dec 31, 2013 1.28 Mn
Sep 30, 2013 1.42 Mn
Jun 30, 2013 1.52 Mn
Mar 31, 2013 1.62 Mn
Dec 31, 2012 1.61 Mn
Sep 30, 2012 247,000.00
Jun 30, 2012 1.44 Mn
Mar 31, 2012 302,000.00
Dec 31, 2011 1.42 Mn
Jun 30, 2011 804,000.00
Dec 31, 2010 536,000.00